Wanpu Yan

Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 <i>EGFR</i>-Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study

Wen‐Zhao Zhong, Ke‐Neng Chen, Chun Chen et al. · Journal of Clinical Oncology · 2019 · 259 citations

Cross-Platform Comparison of Four Leading Technologies for Detecting <i>EGFR</i> Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient Plasma

Ting Xu, Xiaozheng Kang, Xiaofang You et al. · Theranostics · 2017 · 80 citations · Full text

Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial

Wen‐Zhao Zhong, Hong‐Hong Yan, Ke‐Neng Chen et al. · Signal Transduction and Targeted Therapy · 2023 · 74 citations · Full text

Efficacy of transcutaneous electrical acupoint stimulation combined with general anesthesia for sedation and postoperative analgesia in minimally invasive lung cancer surgery: A randomized, double‐blind, placebo‐controlled trial

Jiheng Chen, Yunxiao Zhang, Xiaoxi Li et al. · Thoracic Cancer · 2020 · 59 citations · Full text

The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma

Qi Shi, Luyan Shen, Bin Dong et al. · Cancer Letters · 2018 · 51 citations

Oncology, Esophageal Cancer, Medicine +9